Realcan Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 54.1% in First Half of 2022

Realcan Pharmaceutical Group Co.,Ltd. (瑞康医药集团股份有限公司) (002589.SZ) reported a net profit of 138 million yuan in the first half of 2022, down 54.1% year-on-year.

Meanwhile, the company posted 7.6 billion yuan in revenue, down 40.6% year-on-year.

At the end of the reporting period, it had 25.8 billion yuan in total assets and 16.2 billion yuan in total liabilities, with a liability-to-asset ratio of 62.7%.